Melanie Jay, who studies the treatment and prevention of obesity at NYU Langone Health
Factors like increasing urbanization, improved health insurance coverage, and rising disposable incomes are driving the growing adoption of GLP-1 therapies in the region
CHARLEBOIS: GLP-1 drugs becoming Canadas $3.4 billion food disruption The food industry has always worried about inflation it should now worry about appetite Published May 02, 2026 Last updated May 02, 2026 3 minute read You can save this article by registering for free here
Users say it relies heavily on AI, especially for customer service
Gradual dose titration : Following the prescribed dose escalation schedule is essentialrushing titration significantly increases side effect severity
Thus, these medications deserve consideration as adjunctive therapies for psoriasis, especially in patients with metabolic comorbidities